Get In Touch
Genetic testing is oftenly performed as a part of genetic consultation. These tests are performed either on blood, skin, hair, or amniotic fluid. Genetic tests include the analysis of an individual’s genetic material (DNA or RNA), in order to determine the susceptibility to certain abnormalities or specific disorders or to identify the genetic differences (variants) if any. Currently, genetic tests have developed to a larger extent that in turn facilitates the doctors to detect any defective or missing genes. Specific genetic tests are designed for specific disorders to be identified. There are several instances where a doctor may recommend genetic testing or counseling, for example, if  a couple’s first child suffers from a severe birth defect, or if a woman has  more than two  miscarriages, or a woman who is pregnant at or after age 35. 
 
Genetic consultation is crucial as it helps determination of a genetic or inherited disorder before giving birth to a child and hence avoids the serious birth defects. Diagnostic, pharmacogenetics, prenatal testing, preimplantation testing, presymptomatic and predictive testing and newborn screening constitute several types of genetic tests performed for various reasons. These tests involve the use of reagents of high purity and quality. These are essential in order to ensure accurate results of the tests. Any compromise in the quality and composition of the reagent results in deviation from accurate results and can be misleading.
 
There is an extensive usage of reagents at each and every step of the process such as from deoxyribonucleic acid (DNA) extraction to isolation and purification. With the rapid pace of technological advances in the field of genomics, more and more genetic tests are being implemented in several laboratories across the globe. This is leading to marketing of the genetic tests without proper regulation. Genetic testing finds application in various areas such as determination of genetic disorders, paternity testing, forensics and others. 
 
Three federal agencies namely, Center for Medicare and Medicaid services (CMS), Food and Drug Administration (FDA) and Federal Trade Commission (FTC) play a very significant role in regulating genetic tests. CMS regulates the clinical laboratories and confirms the quality of the lab processes implemented. FDA regulates the marketing of various test kits possessing reagents while FTC puts a check on misleading and false advertising. On July 31, 2014, FDA announced that it would release draft guidelines to regulate laboratory developed tests (LDTs) owing to the increased mismatch between the tests performed in commercial laboratories and the physicians ordered tests. 
 
Genetic tests has the capability to revolutionize the clinical practice however, increased adoption of these tests depends on coverage and reimbursement provided by several insurance providers. If these insurance providers are not willing to pay for the tests, it might result in stagnant growth of the market. There is very limited information available on the reimbursement decisions about genetic testing. The genetic test kits include the standard sample, distilled water, buffer solutions and other extraction and isolation reagents. The usage of these reagent kits is prominent in developed regions such as North America and Europe as compared to Asian countries such as India and China. 
 
The market for genetic testing reagent kits can be analyzed by various geographies such as Europe, North America, Asia Pacific and Rest of the World. Furthermore, this market can be analyzed by various application areas such as new born screening, prenatal testing, forensics and paternity testing. Factors such as regulatory and reimbursement policies govern the commercialization and marketing of genetic testing reagent kits. The major factors favoring the market growth are continuous technological advances, increasing acceptance of genetic consultation and counseling. On other hand factors such as high cost of the procedures and lack of reimbursement and medical coverage restrain the market growth. Danaher Corporation, Sigma-Aldrich Co., LLC. ThermoFisher Scientific, Hologic, Inc., Roche Diagnostics and Abbott Laboratories are some of the key players operating in this market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Genetic Testing Reagents Market